Characteristics of GOLD 2011 grading system in the COPDGene cohort

M. Han, M. Dransfield, D. Curran-Everett, A. Anzueto, F. Martinez, E. Silverman, J. Crapo, G. Washko, B. Make (Ann Arbor, Birmingham, Denver, Boston, San Antonio, United States Of America)

Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Session: GOLD guidelines 2011: new assessment of COPD
Session type: Oral Presentation
Number: 1646
Disease area: Airway diseases

Congress or journal article abstractSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Han, M. Dransfield, D. Curran-Everett, A. Anzueto, F. Martinez, E. Silverman, J. Crapo, G. Washko, B. Make (Ann Arbor, Birmingham, Denver, Boston, San Antonio, United States Of America). Characteristics of GOLD 2011 grading system in the COPDGene cohort. Eur Respir J 2012; 40: Suppl. 56, 1646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013



Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013

Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017



GOLD classifications and mortality in COPD: The HUNT study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013


GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004


FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013



COPD severity using GOLD 2017 in real life: The French Palomb Cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification
Source: Eur Respir J 2013; 42: 647-654
Year: 2013



An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


GOLD classification of COPD and incident lung cancer: findings from a cohort study
Source: Eur Respir J 2004; 24: Suppl. 48, 269s
Year: 2004

Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

Characteristics and longitudinal progression of COPD GOLD B
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002